In 2026, families in New South Wales will have access to a needle-free influenza (flu) vaccine for young children.
The intranasal FluMist nasal spray vaccine will be free for children aged 2 to under 5 years. It will also be available privately for children and teens up to 18 years of age. FluMist will allow parents to protect their young children from severe flu without the stress of a needle, as it is delivered via a painless and simple nasal spray.
Why is it important to vaccinate my child for the flu?
Although flu can be mild for some, it can also cause serious illness and hospitalisation, even in healthy children. Vaccination helps protect them from severe disease and reduces community spread, helping keep vulnerable people safer.
How does it work?
FluMist is a live-attenuated vaccine, meaning that it contains weakened strains of flu viruses that train the immune system to recognise the viruses. but cannot cause illness in healthy individuals.
It is given as a quick spray into each nostril and is rapidly absorbed. If a child sneezes or blows their nose afterwards, the vaccine will still work and does not need to be repeated.
Is it safe and effective?
The intranasal flu vaccine has been safely used in millions of children since 2003 and has been shown to be as effective as injectable flu vaccines, preventing up to half of influenza‑related hospitalisations in young children in the UK.
Common side effects are mild and short-lived, such as a runny nose or other mild respiratory symptoms. The vaccine is not suitable for children who are moderately or severely immunocompromised and should be used with caution for those who are close contacts of people with significant immunocompromise.
Where can my child get the intranasal vaccine?
The intranasal vaccine will be available for free at the GP for children aged two to under five and can be purchased privately for children aged five to under eighteen at GPs and certain pharmacies.
Find out more information about the intranasal flu vaccine in the National Centre for Immunisation Research and Surveillance (NCIRS) Frequently Asked Questions resource.
Immunisation Weekly Update: NSW Health Vaxigrip stock exhausted: temporary stock-sharing licence in place As of 20 July 2026, NSW Health has exhausted its available stock of Vaxgrip vaccine, which is funded for people aged 6 months to less than 5 years under the National Immunisation Program (NIP). NSW Health has…
Immunisation Weekly Update: Diphtheria vaccination for Aboriginal people and travellers Child vaccination FAQ resource Fatal meningococcal Y case in WA Education Diphtheria vaccination for Aboriginal people and travellers Recent diphtheria outbreaks in parts of Australia have prompted ATAGI to release updated advice regarding vaccination in outbreak settings. Clinicians should check…
Immunisation Weekly Update: Co-administration of vaccines guide The NCIRS Co-administration of vaccines guide for immunisation providers was updated July 2026. Most vaccines can be co-administered with other vaccines at the same National Immunisation Program (NIP) schedule point. Separate injection sites should be used where possible, and if the same muscle…
Immunisation Weekly Update: New AIR due/overdue rules for adult vaccines AIR immunisation dashboards Education New AIR due/overdue rules for adult vaccines The Australian Immunisation Register (AIR) has introduced new ‘due’ and ‘overdue’ rules to support recent NIP changes. Pneumococcal due/overdue rules will apply to: Adults 65 years and over Aboriginal…
